Eversept Partners, LP Lantheus Holdings, Inc. Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2023
BUY
$61.42 - $86.29 $1.65 Million - $2.32 Million
26,840 Added 14.91%
206,893 $14.6 Million
Q3 2022

Nov 14, 2022
BUY
$61.42 - $86.29 $1.65 Million - $2.32 Million
26,840 Added 14.91%
206,893 $14.6 Million
Q2 2022

Nov 08, 2023
BUY
$55.54 - $72.65 $10 Million - $13.1 Million
180,053 New
180,053 $11.9 Million
Q2 2022

Aug 15, 2022
BUY
$55.54 - $72.65 $10 Million - $13.1 Million
180,053 New
180,053 $11.9 Million

Others Institutions Holding LNTH

# of Institutions
539
Shares Held
69.9M
Call Options Held
651K
Put Options Held
459K
View Full List

About Lantheus Holdings, Inc.

LNTH Quotes by TradingView
  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.63B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email